Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: Cancer Res. 2013 Dec 3;74(2):621–631. doi: 10.1158/0008-5472.CAN-13-1928

Figure 7. Wyeth-14,643 reduces the size of primary and metastatic GFP-A549 cell-derived tumors.

Figure 7

(A) Images of primary and metastatic tumors visible in the organs of athymic mice untreated (a) or treated with Wyeth-14,643 (b–d) 5 weeks after GFP-A549 cell injection. (B) Tumor area expressed as percentage of area occupied by GFP-positive structures per microscopic field. Values represent the mean +/− s.e.m. of the organs indicated.